Results 281 to 290 of about 1,384,039 (375)

Laterally positioned flap with connective tissue graft to treat deep isolated gingival recessions in the mandibular anterior region: A retrospective case series with 10‐year follow‐up

Clinical Advances in Periodontics, EarlyView.
ABSTRACT Background To evaluate the efficacy and long‐term clinical outcomes of the one‐stage procedure for covering isolated deep gingival recessions (GRs) in the mandibular anterior region employing a laterally positioned flap (LPF) with a connective tissue graft (CTG), with a retrospective case series.
Lucrezia Parma‐Benfenati, Stefano Parma‐Benfenati   +1 more
wiley   +1 more source

Dissimilar Sequelae Caused by Single Dental Trauma: A Case Report with Long-Term Follow-up. [PDF]

Iran Endod J
Alencar MN, Kowaltschuk TC, Juglair MM, Kowalczuck A, Carneiro E, da Silva Neto UX, Westphalen VPD.   +6 more
europepmc   +1 more source

Risk for peri‐implant diseases and defects: Report of workgroup 1 of the joint AO/AAP consensus conference on prevention and management of peri‐implant diseases

Clinical Advances in Periodontics, EarlyView.
Abstract Background A consensus meeting on peri‐implant diseases and treatment was initiated by the American Academy of Periodontology (AAP) and the Academy of Osseointegration (AO) with the goal of developing subject‐ and site‐level risk profiles for peri‐implant diseases and defects, and risk‐informed treatment recommendations. This report summarizes
Purnima S. Kumar, Joseph Kan, Maria Elisa Galarraga‐Vinueza, Guo‐Hao Lin, Alberto Monje, Lorenzo Tavelli, Sandra Stuhr, Yung‐Ting Hsu, Junying Li, Alexandra Tsigarida, Debora Dias, SukirthMurthy Ganesan, Shi Yin, Don Curtis   +13 more
wiley   +1 more source

Management of severe gingival recession using a double papilla connective tissue graft: A 2‐year follow‐up case study

Clinical Advances in Periodontics, EarlyView.
Abstract Background This case study presents the treatment of a 7 mm deep and 5 mm wide RT1 gingival recession on the mandibular left canine in a 30‐year‐old systemically and periodontally healthy female, with the defect being associated with a self‐injurious habit.
Yu‐Chang Wu, Oscar Duran‐Garnica, Hsun‐Liang Chan, Dimitris N. Tatakis   +3 more
wiley   +1 more source

Promising Prodiginins Biological Activities

Chemistry &Biodiversity, EarlyView.
ABSTRACT Prodiginins are a large family of at least 34 pyrrolic compounds, including the well‐studied red pigment prodigiosin. Prodiginins are produced by several microorganisms displaying broad biological activities, including antimicrobial, antiviral, antiparasitic, antiproliferative, and immunosuppressive activities.
María F. Ladetto, Melisa E. Gantner, Boris E. Rodenak‐Kladniew, Santiago Rodriguez, María L. Cuestas, Alan Talevi, Guillermo R. Castro   +6 more
wiley   +1 more source

Guided Endodontic Treatment of Mandibular Incisor with Pulp Canal Obliteration following Dental Trauma: A Case Report. [PDF]

Iran Endod J
Valverde Haro HP, Quille Punina LG, Erazo Conde AD.   +2 more
europepmc   +1 more source

Physician Confidence in Dental Trauma Treatment and the Introduction of a Dental Trauma Decision-Making Pathway for the Pediatric Emergency Department.

Pediatric emergency care, 2018
M. Cully, Jennifer L. Cully, P. Nietert, M. O. Titus   +3 more
semanticscholar   +1 more source

Chemical Components of the Dried Latex of Euphorbia resinifera Berg and Its Medicinal Features

Chemistry &Biodiversity, EarlyView.
ABSTRACT A great deal of research has been carried out on the latex of Euphorbia resinifera Berg, which is an important source of several compounds of therapeutic and medicinal interest. Extraction, synthesis, and hemi synthesis pathways continue to reveal the existence of other new products with anticancer, antioxidant, antidiuretic, and antimalarial ...
Doaa Hammad, El‐Mahdi Ourhzif, Salha Hamri, Hafid Abderrafia, Mostafa Khouili, Maria Dolors Pujol   +5 more
wiley   +1 more source

First‐in‐Human Phase 1 Study to Evaluate the Clinical Pharmacology Properties of RBN‐3143, a Novel Inhibitor of Mono‐Adenosine Diphosphate Ribosyltransferase‐PARP14

Clinical Pharmacology in Drug Development, EarlyView.
Abstract RBN‐3143 is an inhibitor of PARP14 in development for inflammatory diseases. Multiple assessments were conducted to evaluate the clinical pharmacology properties of RBN‐3134. A randomized, double‐blind, placebo‐controlled study assigned healthy volunteers (HVs) to single ascending doses (SADs) (25‐1000 mg) or multiple ascending doses (MADs ...
Thomas M. Polasek, Alexandra Cole, Viviana Bozón, Erika Manyak, Jonathan Novak, Barbara Yang, Briohny A. Johnston, Sudha Parasuraman, Kushal J. Paneliya, Virna Schuck   +9 more
wiley   +1 more source